𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Punding in patients on dopamine agonists for restless leg syndrome

✍ Scribed by Andrew H. Evans; James R. Stegeman

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
312 KB
Volume
24
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Dopamine agonists restore cortical plast
Dopamine agonists restore cortical plasticity in patients with idiopathic restless legs syndrome
✍ Vincenzo Rizzo; Irene AricΓ²; Claudia Mastroeni; Francesca Morgante; Giovanna Lio πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 77 KB

## Abstract In the present work, we aimed at assessing whether patients with idiopathic restless legs syndrome (RLS) showed alterations of sensory‐motor plasticity, an indirect probe for motor learning, within the motor cortex (M1). Previous findings suggest that learning in human M1 occurs through

No evidence for cognitive dysfunction or
No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome
✍ Erika Driver-Dunckley; Donald Connor; Joe Hentz; Marwan Sabbagh; Nina Silverberg πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 330 KB

## Abstract Restless legs syndrome is a common disoder that may interrupt sleep and has been reported to produce daytime fatigue and/or mood changes. This study assessed whether patients with RLS have more cognitive dysfunction and depression than individuals of the same age and education who do no

A case-control study on restless legs sy
A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failure
✍ Giovanni Merlino; Simone Lorenzut; Gian Luigi Gigli; Giulio Romano; Domenico Mon πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

## Abstract Restless legs syndrome (RLS) is a possible consequence of end‐stage renal disease. However, conclusive data on the association between RLS and chronic renal failure (CRF) in nondialyzed patients are still lacking. The aims of this study were: (1) to look for an association between RLS a

Patch application of the dopamine agonis
Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: A double-blind, placebo-controlled pilot study
✍ Karin Stiasny-Kolster; Ralf Kohnen; Erwin Schollmayer; J. Carsten MΓΆller; Wolfga πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 1 views

## Abstract Efficacy and safety of the dopamine agonist rotigotine (RTG) was investigated in patients with moderate to severe idiopathic restless legs syndrome (RLS), including daytime symptoms. Three fixed doses of rotigotine (1.125 mg, 2.25 mg, and 4.5 mg) and placebo were applied by patches (siz